Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Bispecific VEGF-A and Angiopoietin-2 Antagonist RO-101 Preclinical Efficacy in Model of Neovascular Eye Disease

PaperCitations, authors & open-access status

Bispecific VEGF-A and Angiopoietin-2 Antagonist RO-101 Preclinical Efficacy in Model of Neovascular Eye Disease is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 5 citations, 2024 year and gold oa status.

5
Citations
2024
Year
gold
OA Status

Related on ScholarIQ

Anne Strong Caldwell
Author
Ophthalmology Science
Journal
Angiogenesis and VEGF in Cancer
Topic
Angiogenesis and VEGF in Cancer
Topic
Lipid metabolism and disorders
Topic
Retinal Diseases and Treatments
Topic
470M+ articles · free account